Team:Paris/Addressing testing

From 2009.igem.org

(Difference between revisions)
(→Export system)
(→Functional Testing:)
 
(18 intermediate revisions not shown)
Line 121: Line 121:
-
|bgcolor="#E0E3FE"|'''PCR :'''
+
|bgcolor="#E0E3FE"|
-
 
+
-
-
-
|bgcolor="#CBD1FD"|'''PCR :'''
+
|bgcolor="#CBD1FD"|
-
 
+
-
-
-
|bgcolor="#BCCDFD"|'''PCR :'''
+
|bgcolor="#BCCDFD"|  
-
 
+
-
-
Line 136: Line 133:
ok
ok
-
|bgcolor="#E0E3FE"|'''Verification on gel :'''
+
|bgcolor="#E0E3FE"|
-
 
+
-
-
-
|bgcolor="#CBD1FD"|'''Verification on gel :'''
+
|bgcolor="#CBD1FD"|
-
-
-
|bgcolor="#BCCDFD"|'''Verification on gel :'''
+
|bgcolor="#BCCDFD"|
-
 
+
-
-
 +
|- style="background: #bebebe; text-align: center;"   
|- style="background: #bebebe; text-align: center;"   
Line 153: Line 149:
ok
ok
-
|bgcolor="#E0E3FE"| '''Purification on gel :'''
+
|bgcolor="#E0E3FE"|  
-
 
+
-
-
-
|bgcolor="#CBD1FD"|'''Purification on gel :'''
 
 +
|bgcolor="#CBD1FD"|
-
-
-
|bgcolor="#BCCDFD"|'''Purification on gel :'''
 
 +
|bgcolor="#BCCDFD"|
-
-
 +
|- style="background: #d8d8d8; text-align: center;"
|- style="background: #d8d8d8; text-align: center;"
Line 181: Line 177:
ClyA Cter-RFP Nter vector PSB1A3 E/X
ClyA Cter-RFP Nter vector PSB1A3 E/X
-
|bgcolor="#CBD1FD"|'''Digestion:'''
+
|bgcolor="#CBD1FD"|
-
 
+
-
-
-
|bgcolor="#BCCDFD"|'''Digestion:'''
+
|bgcolor="#BCCDFD"|
-
 
+
-
-
Line 197: Line 191:
ok
ok
-
|bgcolor="#CBD1FD"|'''Verification digestion:'''
+
|bgcolor="#CBD1FD"|-
-
 
+
|bgcolor="#BCCDFD"|
-
-
-
|bgcolor="#BCCDFD"|'''Verification digestion:'''
 
-
 
-
-
 
-
 
|- style="background: #d8d8d8; text-align: center;"
|- style="background: #d8d8d8; text-align: center;"
Line 220: Line 210:
-
-
-
|bgcolor="#BCCDFD"|'''Ligation:'''
+
|bgcolor="#BCCDFD"|
-
+
 
-
-
+
|- style="background: #bebebe; text-align: center;"   
|- style="background: #bebebe; text-align: center;"   
-
|bgcolor="#F8F8F8"| '''PCR colony :'''
+
|bgcolor="#F8F8F8"| '''Colony PCR :'''
ok
ok
Line 235: Line 224:
|bgcolor="#CBD1FD"|'''Colony PCR :'''
|bgcolor="#CBD1FD"|'''Colony PCR :'''
-
-
+
ok
-
|bgcolor="#BCCDFD"|'''Colony PCR :'''
+
|bgcolor="#BCCDFD"|
-
-
 
Line 253: Line 241:
|bgcolor="#CBD1FD"|'''Miniprep:'''
|bgcolor="#CBD1FD"|'''Miniprep:'''
-
-
+
clone 3
-
|bgcolor="#BCCDFD"|'''Miniprep:'''
+
 
 +
clone 5
 +
 
 +
|bgcolor="#BCCDFD"|
-
-
 
Line 270: Line 260:
|bgcolor="#CBD1FD"|'''Sequencing :'''
|bgcolor="#CBD1FD"|'''Sequencing :'''
-
-
+
ok
-
|bgcolor="#BCCDFD"|'''Sequencing :'''
+
 +
|bgcolor="#BCCDFD"|
-
-
 +
|- style="background: #d8d8d8; text-align: center;"   
|- style="background: #d8d8d8; text-align: center;"   
Line 293: Line 284:
|bgcolor="#CBD1FD"|'''Stock glycerol'''
|bgcolor="#CBD1FD"|'''Stock glycerol'''
-
-
+
pBAD ClyA RFP : S89 (clone 3)
-
|bgcolor="#BCCDFD"|'''Stock glycerol'''
+
-
-
+
pBAD ClyA RFP: S90 (clone 5)
 +
 
 +
|bgcolor="#BCCDFD"|
Line 308: Line 300:
-
PBAD ClyA RFP on PSB3T5 was transformed into Delta Tol bacteria , in this case we are supposed to see fluorescent vesicles went the medium contains 1 % arabinose , and to have no fluorescent on 1% glucose.
+
PBAD ClyA RFP on PSB3T5 was transformed into Delta Tol bacteria , in this case we are supposed to see fluorescent vesicles when the medium contains 1 % arabinose , and to have no fluorescent on 1% glucose.
 +
 
 +
 
 +
To learn more, see the [[Team:Paris/Conclusion | Conclusion page]]
Line 335: Line 330:
|width="300px" ; bgcolor="#CBD1FD"| Column 3
|width="300px" ; bgcolor="#CBD1FD"| Column 3
|width="300px" ; bgcolor="#BCCDFD"| Column 4
|width="300px" ; bgcolor="#BCCDFD"| Column 4
-
 
|- style="background: #bebebe; text-align: center;"
|- style="background: #bebebe; text-align: center;"
Line 342: Line 336:
TatABCE matrix :
TatABCE matrix :
-
|bgcolor="#E0E3FE"|'''PCR :'''
+
|bgcolor="#E0E3FE"|-
-
|bgcolor="#CBD1FD"|'''PCR :'''
+
|bgcolor="#CBD1FD"|-
-
|bgcolor="#BCCDFD"|'''PCR :'''
+
|bgcolor="#BCCDFD"|-
 +
 
|- style="background: #d8d8d8; text-align: center;"
|- style="background: #d8d8d8; text-align: center;"
Line 351: Line 346:
ok
ok
-
|bgcolor="#E0E3FE"|'''Verification on gel :'''
+
|bgcolor="#E0E3FE"|-
-
 
+
-
-
+
-
|bgcolor="#CBD1FD"|'''Verification on gel :'''
+
|bgcolor="#CBD1FD"|
-
-
-
|bgcolor="#BCCDFD"|'''Verification on gel :'''
+
|bgcolor="#BCCDFD"|
-
-
Line 367: Line 360:
ok
ok
-
|bgcolor="#E0E3FE"|'''Purification on gel :'''
+
|bgcolor="#E0E3FE"|
-
-
-
|bgcolor="#CBD1FD"|'''Purification on gel :'''
+
|bgcolor="#CBD1FD"|
-
-
-
|bgcolor="#BCCDFD"|'''Purification on gel :'''
+
|bgcolor="#BCCDFD"|
-
-
Line 383: Line 376:
|bgcolor="#F8F8F8"|'''Digestion:'''  
|bgcolor="#F8F8F8"|'''Digestion:'''  
-
TatABCE
+
none
|bgcolor="#E0E3FE"|'''Digestion:'''  
|bgcolor="#E0E3FE"|'''Digestion:'''  
 +
none
|bgcolor="#CBD1FD"|'''Digestion:'''  
|bgcolor="#CBD1FD"|'''Digestion:'''  
 +
none
|bgcolor="#BCCDFD"|'''Digestion:'''  
|bgcolor="#BCCDFD"|'''Digestion:'''  
 +
none
|- style="background: #bebebe; text-align: center;"   
|- style="background: #bebebe; text-align: center;"   
-
|bgcolor="#F8F8F8"|'''Verification digestion:'''
+
|bgcolor="#F8F8F8"|'''Digestion checking:'''
 +
none
-
ok
+
|bgcolor="#E0E3FE"|'''Digestion checking:'''
 +
none
-
|bgcolor="#E0E3FE"|'''Verification digestion:'''
 
-
-
+
|bgcolor="#CBD1FD"|'''Digestion checking:'''
-
|bgcolor="#CBD1FD"|'''Verification digestion:'''
+
none
 +
|bgcolor="#BCCDFD"|'''Digestion checking:'''
-
-
+
none
-
|bgcolor="#BCCDFD"|'''Verification digestion:'''
+
-
 
+
-
-
+
Line 409: Line 404:
|bgcolor="#F8F8F8"|'''Ligation:'''  
|bgcolor="#F8F8F8"|'''Ligation:'''  
-
TatABCE
+
none
-
 
+
|bgcolor="#E0E3FE"|'''Ligation:'''  
|bgcolor="#E0E3FE"|'''Ligation:'''  
 +
none
|bgcolor="#CBD1FD"|'''Ligation:'''  
|bgcolor="#CBD1FD"|'''Ligation:'''  
 +
none
|bgcolor="#BCCDFD"|'''Ligation:'''  
|bgcolor="#BCCDFD"|'''Ligation:'''  
 +
none
|- style="background: #bebebe; text-align: center;"   
|- style="background: #bebebe; text-align: center;"   
|bgcolor="#F8F8F8"|'''Colony PCR :'''
|bgcolor="#F8F8F8"|'''Colony PCR :'''
-
 
+
none
-
ok
+
|bgcolor="#E0E3FE"|'''Colony PCR :'''
|bgcolor="#E0E3FE"|'''Colony PCR :'''
-
 
+
none
-
-
+
|bgcolor="#CBD1FD"|'''Colony PCR :'''
|bgcolor="#CBD1FD"|'''Colony PCR :'''
-
 
+
none
-
-
+
|bgcolor="#BCCDFD"|'''Colony PCR :'''
|bgcolor="#BCCDFD"|'''Colony PCR :'''
-
 
+
none
-
-
+
|- style="background: #d8d8d8; text-align: center;"
|- style="background: #d8d8d8; text-align: center;"
|bgcolor="#F8F8F8"|'''Miniprep:'''
|bgcolor="#F8F8F8"|'''Miniprep:'''
-
STOPPED
+
none
|bgcolor="#E0E3FE"|'''Miniprep:'''
|bgcolor="#E0E3FE"|'''Miniprep:'''
-
-
+
none
|bgcolor="#CBD1FD"|'''Miniprep:'''
|bgcolor="#CBD1FD"|'''Miniprep:'''
-
-
+
none
|bgcolor="#BCCDFD"|'''Miniprep:'''
|bgcolor="#BCCDFD"|'''Miniprep:'''
-
-
+
none
|- style="background: #bebebe; text-align: center;"   
|- style="background: #bebebe; text-align: center;"   
|bgcolor="#F8F8F8"|'''Sequencing :'''
|bgcolor="#F8F8F8"|'''Sequencing :'''
-
-
+
none
|bgcolor="#E0E3FE"|'''Sequencing :'''
|bgcolor="#E0E3FE"|'''Sequencing :'''
-
-
+
none
|bgcolor="#CBD1FD"|'''Sequencing :'''
|bgcolor="#CBD1FD"|'''Sequencing :'''
-
-
+
none
|bgcolor="#BCCDFD"|'''Sequencing :'''
|bgcolor="#BCCDFD"|'''Sequencing :'''
-
-
+
none
|- style="background: #d8d8d8; text-align: center;"   
|- style="background: #d8d8d8; text-align: center;"   
|bgcolor="#F8F8F8"| '''Stock glycerol:'''
|bgcolor="#F8F8F8"| '''Stock glycerol:'''
-
-
+
none
|bgcolor="#E0E3FE"|'''Stock glycerol'''
|bgcolor="#E0E3FE"|'''Stock glycerol'''
-
-
+
none
|bgcolor="#CBD1FD"|'''Stock glycerol'''
|bgcolor="#CBD1FD"|'''Stock glycerol'''
-
-
+
none
|bgcolor="#BCCDFD"|'''Stock glycerol'''
|bgcolor="#BCCDFD"|'''Stock glycerol'''
-
-
+
none
|}
|}

Latest revision as of 03:53, 22 October 2009

iGEM > Paris > WetLab > Addressing


WetLab - Addressing the message



Global constructions :


The green color means the experiment was a success


plasmid = PSB3T5




Experiments ran :


Column 1 Column 2 Column 3 Column 4
PCR :

pBAD: plate 2008


ClyA Cterm matrix : F4

Oligo :O10 and O31 TM :55°C


mRFP Nterm plasmid : pSB1A3

Oligo :O57 and O58 TM :


ClyA Nterm matrix : F4

Oligo : O32 and O9 TM :55°C


mRFP Cterm matrix : pSB1A3

Oligo :O59 and O60 TM :


-

-

-

Verification on gel :

ok

-

-

-


Purification on gel :

ok

-


-

-


Digestion:

ClyA Cterm S/P


RFP Nterm X/P


pBAD vector : ? E/S


Digestion:

ClyA Cter-RFP Nter vector PSB1A3 E/X

-

-

Verification digestion:

ok

Verification digestion:

ok

-

-

Ligation:

ClyA Cter-RFP Nter vector PSB1A3

Ligation:

PBAD E/S ClyA Cter-RFP Nter PSB1A3 E/X (x2)


PBAD S/P ClyA Cter-RFP Nter PSB2K3 X/P (x2)

Ligation:

-


Colony PCR :

ok

Colony PCR :

ok

Colony PCR :

ok


Miniprep:

clone :

Miniprep:

clone :

Miniprep:

clone 3

clone 5


Sequencing :

ok

Sequencing :

ok

Sequencing :

ok

-


Stock glycerol:

ClyA CTer: S47(clone 3) and S48(clone 7)

ClyA Nter: S72

RFP Cter: S55 (Clone 3)

RFP Nter: S56 (Clone 3)


Stock glycerol

Cly A(Cter)-(Nter)RFP: S72(clone 8)

Stock glycerol

pBAD ClyA RFP : S89 (clone 3)

pBAD ClyA RFP: S90 (clone 5)



Functional Testing:

PBAD ClyA RFP was transformed into Top10 bacteria in order to localize the fluorescence, we are supposed to have a superior fluorescence in the membrane.


PBAD ClyA RFP on PSB3T5 was transformed into Delta Tol bacteria , in this case we are supposed to see fluorescent vesicles when the medium contains 1 % arabinose , and to have no fluorescent on 1% glucose.


To learn more, see the Conclusion page


Export system

We finally thought that it won't be neccesary to overexpress the Tat system, nevertheless we have run a few experiments before starting to focus on others parts of the project.



Experiments ran :


Column 1 Column 2 Column 3 Column 4
PCR :

TatABCE matrix :

- - -


Verification on gel :

ok

-

-

-

Purification on gel :

ok

-

-

-


Digestion:

none

Digestion:

none

Digestion:

none

Digestion:

none

Digestion checking:

none

Digestion checking:

none


Digestion checking:

none

Digestion checking:

none


Ligation:

none

Ligation:

none

Ligation:

none

Ligation:

none

Colony PCR :

none

Colony PCR :

none

Colony PCR :

none

Colony PCR :

none

Miniprep:

none

Miniprep:

none

Miniprep:

none

Miniprep:

none

Sequencing :

none

Sequencing :

none

Sequencing :

none

Sequencing :

none

Stock glycerol:

none

Stock glycerol

none

Stock glycerol

none

Stock glycerol

none


Retrieved from "http://2009.igem.org/Team:Paris/Addressing_testing"